Lenalidomide, a small thalidomide derivative that inhibits TNF‐α production, reduced α‐syn accumulation, astrogliosis and microgliosis, in MSA mice, but greater effects were found in combination with a single‐chain antibody targeting α‐syn modified for improved central nervous system penetration (CD5‐D5).101. This evidence concerns the gene TNF and multiple system atrophy.